Cargando…
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research
The expanding CRISPR-Cas9 technology is an easily accessible, programmable, and precise gene-editing tool with numerous applications, most notably in biomedical research. Together with advancements in genome and transcriptome sequencing in the era of metadata, genomic engineering with CRISPR-Cas9 me...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447755/ https://www.ncbi.nlm.nih.gov/pubmed/30989086 http://dx.doi.org/10.1016/j.omtm.2019.02.008 |
_version_ | 1783408563410960384 |
---|---|
author | You, Liting Tong, Ruizhan Li, Mengqian Liu, Yuncong Xue, Jianxin Lu, You |
author_facet | You, Liting Tong, Ruizhan Li, Mengqian Liu, Yuncong Xue, Jianxin Lu, You |
author_sort | You, Liting |
collection | PubMed |
description | The expanding CRISPR-Cas9 technology is an easily accessible, programmable, and precise gene-editing tool with numerous applications, most notably in biomedical research. Together with advancements in genome and transcriptome sequencing in the era of metadata, genomic engineering with CRISPR-Cas9 meets the developmental requirements of precision medicine, and clinical tests using CRISPR-Cas9 are now possible. This review summarizes developments and established preclinical applications of CRISPR-Cas9 technology, along with its current challenges, and highlights future applications in translational research. |
format | Online Article Text |
id | pubmed-6447755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | American Society of Gene & Cell Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-64477552019-04-15 Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research You, Liting Tong, Ruizhan Li, Mengqian Liu, Yuncong Xue, Jianxin Lu, You Mol Ther Methods Clin Dev Article The expanding CRISPR-Cas9 technology is an easily accessible, programmable, and precise gene-editing tool with numerous applications, most notably in biomedical research. Together with advancements in genome and transcriptome sequencing in the era of metadata, genomic engineering with CRISPR-Cas9 meets the developmental requirements of precision medicine, and clinical tests using CRISPR-Cas9 are now possible. This review summarizes developments and established preclinical applications of CRISPR-Cas9 technology, along with its current challenges, and highlights future applications in translational research. American Society of Gene & Cell Therapy 2019-03-15 /pmc/articles/PMC6447755/ /pubmed/30989086 http://dx.doi.org/10.1016/j.omtm.2019.02.008 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article You, Liting Tong, Ruizhan Li, Mengqian Liu, Yuncong Xue, Jianxin Lu, You Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research |
title | Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research |
title_full | Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research |
title_fullStr | Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research |
title_full_unstemmed | Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research |
title_short | Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research |
title_sort | advancements and obstacles of crispr-cas9 technology in translational research |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447755/ https://www.ncbi.nlm.nih.gov/pubmed/30989086 http://dx.doi.org/10.1016/j.omtm.2019.02.008 |
work_keys_str_mv | AT youliting advancementsandobstaclesofcrisprcas9technologyintranslationalresearch AT tongruizhan advancementsandobstaclesofcrisprcas9technologyintranslationalresearch AT limengqian advancementsandobstaclesofcrisprcas9technologyintranslationalresearch AT liuyuncong advancementsandobstaclesofcrisprcas9technologyintranslationalresearch AT xuejianxin advancementsandobstaclesofcrisprcas9technologyintranslationalresearch AT luyou advancementsandobstaclesofcrisprcas9technologyintranslationalresearch |